Old Web
English
Sign In
Acemap
>
authorDetail
>
A. B. van der Waart
A. B. van der Waart
Radboud University Nijmegen
Cancer research
Immunotherapy
Interleukin 15
Progenitor cell
Cancer immunotherapy
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells (Cancer Immunology, Immunotherapy, (2021), 70, 5, (1305-1321), 10.1007/s00262-020-02749-8)
2021
Cancer Immunology, Immunotherapy
J. M. R. Van der Meer
Ralph J. A. Maas
K. Guldevall
K. Klarenaar
P.K.J.D. de Jonge
J. S. Hoogstad-van Evert
A. B. van der Waart
Jeannette Cany
J T Safrit
J.H. Lee
Esther Wagena
Peter Friedl
B. Önfelt
Leon F.A.G. Massuger
Nicolaas Schaap
Joop H. Jansen
Willemijn Hobo
Harry Dolstra
Show All
Source
Cite
Save
Citations (0)
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.
2020
Cancer Immunology, Immunotherapy
J. M. R. Van der Meer
Ralph J. A. Maas
K. Guldevall
K. Klarenaar
P.K.J.D. de Jonge
J. S. Hoogstad-van Evert
A. B. van der Waart
Jeannette Cany
J T Safrit
J.H. Lee
E. Wagena
Peter Friedl
B. Önfelt
Leon F.A.G. Massuger
Nicolaas Schaap
Joop H. Jansen
Willemijn Hobo
Harry Dolstra
Show All
Source
Cite
Save
Citations (4)
1